Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
AHN-12 Biodistribution in Advanced Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE4
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE3
Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE3
Revlimid in Transfusion Dependent Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias
- Status
- COMPLETED
- Phase
- PHASE1
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients
- Status
- COMPLETED
- Phase
- PHASE1
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
- Status
- COMPLETED
- Phase
- N/A
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure
- Status
- UNKNOWN
- Phase
- PHASE2
Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
- Status
- COMPLETED
- Phase
- PHASE2
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Temsirolimus in Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Does Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients?
- Status
- COMPLETED
- Phase
- PHASE2
Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003
- Status
- COMPLETED
- Phase
- N/A